Secondly, c-Met is involved in malignant biological behavior, such as large tumor size, high histological grade and distant metastasis, and combination therapy with c-Met inhibitor in future will dramatically reduce mortality in invasive breast cancer. Here, MET is linked to invasive breast carcinoma.